ScholarIQanswers from OpenAlex

Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature

PaperCitations, authors & open-access status

Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature have?

ScholarIQcitation count

Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature published?

ScholarIQyear

Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature has 2025 year in the ScholarIQ index.

What is the open-access status of Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature?

ScholarIQoa status

Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature has closed oa status in the ScholarIQ index.

What is the DOI of Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature?

ScholarIQdoi

The DOI for Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature is on the source record.

What is the PMID of Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature?

ScholarIQpmid

The PMID for Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature is on the source record.

What is the OpenAlex record for Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature?

ScholarIQopenalex

The OpenAlex for Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial